Filters:
Investigator: Ihab Hajjar1 Projects | 1 Researchers | $944,115 Invested
2015
Emory University
Ihab Hajjar, MD, MS
Effect of candesartan on prodromal Alzheimer's Disease and its related biomarkers
Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Ihab Hajjar, MD, MS
Effect of candesartan on prodromal Alzheimer's Disease and its related biomarkers